Show newer

RT @WHO: It is World Week!

🧑‍⚕️Doctors
🧑‍⚕️Nurses
🧑‍⚕️Care workers
🧑‍⚕️Technicians
🧑‍⚕️Pharmacists
🧑‍⚕️Midwives
& many others

are working tirelessly to keep us safe & healthy. We must invest & protect the health workforce to ensure .

🐦🔗: n.respublicae.eu/EMA_News/stat

The programme aims to build a strong . Take the targeted consultation and help shape its future priorities and needs

Send in your contribution by 8 May 2023 ⤵
ec.europa.eu/newsroom/sante/ne

🐦🔗: n.respublicae.eu/EU_HaDEA/stat

When it comes to pandemic prevention, preparedness and response, we are stronger together.

DG @SandraGallina participates in meetings of the Intergovernmental Negotiating Body, alongside @DrTedros


RT @SandraGallina: Starting INB5 work!

🐦🔗: n.respublicae.eu/EU_Health/sta

RT @EU_HaDEA: New calls for proposals📣

has published 4 two-stage calls under !

Topics include:
-Staying healthy
-Living and working in a healthy environment
-Access to innovative
-New tools and technologies

Learn more➡ hadea.ec.europa.eu/news/4-two-

🐦🔗: n.respublicae.eu/EMA_News/stat

Deadline approaching 📢

Are you a medical device manufacturer? Check out EMA’s scientific advice pilot for high-risk .

📌 Apply before 15 April to be considered in the first selection!
🔗ema.europa.eu/en/human-regulat
RT @EMA_News: EMA launches a scientific advice pilot for high-risk .

Prioritised devices include:
🩹 devices for rare conditions
⚕️ devices to tre…

🐦🔗: n.respublicae.eu/EMA_News/stat

EMA extends a warm thank you to all and that supported the Agency’s activities in 2022 🙏

Your involvement in our scientific committees, expert groups, working parties and workshops on various strategic topics is a great asset for EMA's work.

🐦🔗: n.respublicae.eu/EMA_News/stat

is our biggest-ever investment in public health, but its success lies in collaboration.

Help us shape the priorities, orientation & needs for the future by taking part in this survey.

Deadline: 8 May 2023

🐦🔗: n.respublicae.eu/EU_Health/sta

DARWIN EU® has had an exciting first year!

The first 4⃣ studies start to show the benefits of the network in generating real-world evidence () to support regulatory decision making. This year, will onboard 1⃣0⃣ additional data partners.

👉ema.europa.eu/en/news/darwin-e

🐦🔗: n.respublicae.eu/EMA_News/stat

Medical Devices 🏥🩺🌡🕹

Do you have questions on the extension of the MDR transitional period?

We have a brand new Q&A on practical aspects related to the amended regulation ⬇

🐦🔗: n.respublicae.eu/EU_Health/sta

When enough people in a population are immune to an infectious disease, it is unlikely to spread around. This is known as .

Find out about the benefits of vaccinations at: vaccination-info.eu/ in YOUR language!

🐦🔗: n.respublicae.eu/ECDC_EU/statu

Don't miss the 2023 call📢

The 4 topics address:

-Poorly-understood tumour-host interactions
-Prevention through behavioural change
-Clinical trials on diagnostics
-Quality of life for childhood patients

⌛12/04 ➡hadea.ec.europa.eu/news/2023-h

🐦🔗: n.respublicae.eu/EU_HaDEA/stat

A clear message at yesterday's meeting: Medical devices save lives, we cannot risk any shortages.


RT @SKyriakidesEU: Speaking to the 23rd
➡️ the medical devices sector plays a crucial role in the daily lives of patients.

Cooperation at the 🌍 level is essential to continue promoting innovation and making safe medical devices affordable and accessible to all citizens.

🐦🔗: n.respublicae.eu/EU_Health/sta

RT @europarlpress: ‼️ STARTING SHORTLY ‼️

Exchange of views with Commissioner @SKyriakidesEU and Emer Cooke, Executive Director of the @EMA_News on preparing for future pandemics.

LIVE from 15.00 - watch here: eptwitter.eu/qBB6

🐦🔗: n.respublicae.eu/EMA_News/stat

The agenda of EMA's human medicines committee is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
ema.europa.eu/en/documents/age

🐦🔗: n.respublicae.eu/EMA_News/stat

Show older
Mastodon

A Mastodon forum for the discussion of European Union matters. Not run by the EU. Powered by PleromaBot, Nitter and PrivacyDev.net.